Filter
91
Filtered Results: 91
Text search:
M.
Ranganathan
et
al.
Featured
Recommendations
10
New Publications
6
Language
Document type
Studies & Reports
39
No document type
30
Guidelines
14
Manuals
4
Training Material
2
Strategic & Response Plan
2
Countries / Regions
Global
10
Brazil
6
Russia
3
India
3
Mozambique
2
Asia
2
Guinea-Bissau
2
Eastern Europe
2
Angola
2
Nepal
1
Ukraine
1
Burkina Faso
1
USA
1
Latin America and the Carribbean
1
Western and Central Europe
1
Uganda
1
Chad
1
Botswana
1
South Sudan
1
Indonesia
1
Authors & Publishers
Publication Years
Category
COVID-19
5
Studies & Reports
4
Guidelines
3
Non-communicable Diseases
3
Disease Prevention & Control
3
Communicable Diseases
2
Drugs & Medical Equipment
2
Capacity Building
2
Malaria
2
TB
2
Paediatrics
1
Clinical Training
1
Public Health
1
Pharmacy & Technology
1
Trachoma
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
Lymphaticfilariasis
1
Planetary Health
1
Infection Control & Prevention (IPC)
1
Clinical Guidelines
1
Policies & Guidelines HIV & TB
1
Women & Child Health
1
Community Health
1
Disabilities
1
Immunization
1
General Guidelines
1
Leprosy
1
NTDs & Others
1
Primary Health Care
1
Parasitology
1
Toolboxes
Clinical Guidelines
9
Health Financing Toolbox
4
Policies & Strategies
3
Prevention & Control
3
Children & Adolescents
3
Reports
3
Essential Medicines & Medical Devices
3
Planetary Health
3
Essential Medicines & Devices Lists
3
Mental Health
3
Health Impact & Climate Change
3
Childhood TB
2
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
2
Children/Adolescents Mental Disorders
2
Country specific documents
2
Hospital Readiness/Essential Health Services
2
Climate Change General
2
Clean air
2
General Information & Methodology
2
Prevention & Strategies
2
Studies & Reports
2
Dengue Prevention & Control
2
Eastern Europe & Central Asia
2
Disability Rights & Convention
1
Drugs
1
General Reports
1
Country specific
1
Adults
1
Pediatrics
1
Policies & Programmes
1
Curricula & Core Competencies
1
Laboratory
1
Prevention & Control
1
Studies & Reports
1
Human Rights
1
Epilepsy
1
IEC Substance Use Disorders
1
Communication & Training
1
Cannabis
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Health Personnel
1
Infection Prevention & Hygiene
1
Global Impact: Socio-economic, health services, TB & HIV
1
Protection of Vulnerable Groups
1
Gender Aspects
1
TB/HIV
1
Hygiene
1
Ethics
1
Nurses
1
Overview
1
Brazil
1
Rational use of Medicine
1
Guiding documents and principles
1
Land-system change
1
Biogeochemical flows
1
Epilepsy
1
Prevention & Measures
1
Antimicrobial Resistance (AMR)
1
Others
1
Ethics
1
Health Care In Conflict Settings
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Air Pollution
1
Detection & Diagnosis
1
Asia and Pacific
1
Drug resistant TB
1
General Aspects
1
Disease Prevention & Control
1
Training
1
Research & Access
1
Assessment
1
HIV and coinfection
1
TB/HIV Coinfection
1
Zika Prevention & Control
1
Tobacco
1
Clinical Guidelines
1
HIV service delivery
1
TB
1
Unaccompanied Refugee Minors
1
Reports & Studies
1
SEAR (South-east Asia Region)
1
Seizures constitute the most common neurological problem in children and the majority of epilepsy has its onset in childhood. Appropriate diagnosis and management of childhood epilepsy is essential to improve quality of life in these children. Evidence-based clinical practice guidelines, modified to...
Prepared as an outcome of ICMR Subcommittee on Buccal Mucosa Cancer | This consensus document on management of Buccal Mucosa cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. ...
Training Module on Malaria
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
Pandemics and outbreaks have differential impacts on women and men. From risk of exposure and biological susceptibility to infection to the social and economic implications, individuals’ experiences are likely to vary according to their biological and gender characteristics and...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
23 March 2021
The meeting addressed the last key area, that is, determining the best method or combination of diagnostic methods for a control programme for S. stercoralis infections in humans.
Dr Montresor’s presentation highlighted that while there is currently no “gold standard” for the...
Background paper 8
The Independent Panel for Pandemic Preparedness and Response
May 2021
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
The Faster We Go, the Health We'll Be.
The report outlines five climate solutions that research shows will deliver immediate, often localized, health and equity benefits. Our focus is on the solutions that proactively advance both health and health equity, recognizing that some of us face greater h...
Update, 23 de junio de 2022
An estimated 1.3 billion people – or 16% of global population worldwide – experience a significant disability today. Persons with disabilities have the right to the highest attainable standard of health as those without disabilities. However, the WHO Global report on health equity for persons w...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
The content of these guidelines goes beyond the technicalities of medical needs with additional insights into community empowerment, possible access to welfare and economic opportunities and similar issues. If these are adequately explored, the health and quality of life of people affected and their...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
